US Reversal Frames Issues In Myriad's Appeal

The past few weeks have seen important developments in Myriad Genetics Inc.'s appeal to the U.S. Court of Appeals for the Federal Circuit in Association for Molecular Pathology, et al., v....

Already a subscriber? Click here to view full article